Hers vs Sprout Health

Choose hers if: You are female with multiple health needs beyond weight loss - obesity + PCOS hair loss, obesity + depression/anxiety, obesity + hormonal skin issues - benefiting from coordinated women-specific medical care. You value what 7+ years of operating history and a public company (NYSE: HIMS) buy you: confidence in treatment continuity for chronic management. You want women's health expertise understanding female hormonal influences on weight (PCOS, perimenopause, reproductive factors) with integration addressing interconnected conditions through medical team. You prioritize platform technology, multi-category coordination, and certainty over moderate cost savings. You accept higher costs ($199-349/month) for women-specific care and service capabilities.

Choose Sprout if: You seek value-tier pricing ($169-279/month) providing meaningful savings of $360-840 annually compared to hers while maintaining reasonable service quality above ultra-budget providers. You have straightforward weight loss needs without complications benefiting from women-specific expertise or multi-condition coordination. You need exclusively weight loss medication without other health services, and single-category platform adequately serves your needs. You serve any gender (universal access versus hers female-only policy). You can accept emerging platform (2 years of history) that can operate, but without the long record of mature competitors. You prioritize moderate cost savings against Sprout's two years in business over full-spectrum women's health integration and maximum certainty.

Bottom line: hers and Sprout represent different positions on the cost-quality-specialization spectrum - hers offers women's health integration ($199-349/month) with 7+ proven years, multi-category coordination, female health expertise, and public company stability, serving female patients with multiple interconnected health concerns, while Sprout provides value-tier single-category weight loss ($169-279/month) with universal gender access, 2 years emerging platform status, straightforward medication focus, and meaningful cost savings ($360-840 annually) for patients prioritizing moderate affordability over full services. For women with multiple health needs, women-specific expertise requirements, or coordination with hormonal/reproductive factors, hers delivers superior value through expertise, established operations, women-care, and certainty despite higher costs. For patients seeking value-tier weight loss balancing moderate savings against a shorter history, straightforward single-condition needs, or universal gender access, Sprout provides middle-ground option between ultra-budget startups (<1 year, highest risk) and established platforms (7+ years, premium pricing) - offering reasonable affordability ($360-840 annual savings) with emerging platform status (2 years) that has held up so far, for patients comfortable with moderate uncertainty in exchange for meaningful cost reduction.